Daiwa Securities Group Inc. Spring Works Therapeutics, Inc. Transaction History
Daiwa Securities Group Inc.
- $22.4 Billion
- Q4 2024
A detailed history of Daiwa Securities Group Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 245 shares of SWTX stock, worth $12,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
245
Previous 291
15.81%
Holding current value
$12,223
Previous $9,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$357 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$280 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$173 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$163 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$150 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.11B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...